Regulation of Apoptotic Signaling Pathways by Alpha-Crystallins in the Ocular Len
Regulation of Apoptotic Signaling Pathways by Alpha-Crystallins in the Ocular Len
批准号:
7843604
负责人:
David W Li
金额:
$51.6万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-01 至 2012-05-31
关键词:
AdultAgeApoptosisApoptoticAstrocytesBCL-Xs proteinCardiac MyocytesCataractCellsCessation of lifeChickensCrystalline LensCrystallinsDevelopmentDevelopmental ProcessEnsureEpithelial CellsExogenous FactorsFamilyFamily memberGene ExpressionGeneticHeat shock proteinsHereditary DiseaseKnock-outKnockout MiceLaboratoriesLaboratory FindingLens FiberMAP Kinase Activation PathwayMAP Kinase GeneMAP Kinase Regulation PathwayMAPK Signaling Pathway PathwayMAPK14 geneMEKsMitochondriaMitogen-Activated Protein KinasesMolecularMolecular ChaperonesMusMutationNeurogliaPIK3CG genePathogenesisPathologyPathway interactionsPhosphorylationPhosphotransferasesPlayPoint MutationProcessProtein FamilyRegulationRoleSignal PathwaySignal TransductionStagingStressUp-Regulationalpha-Crystallinsbasecaspase-3caspase-6fiber cellin vivolenslens proteinlens transparencymemberpreventpro-caspase-3
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Recent studies have shown that a-crystallins are strong anti-apoptotic regulators, preventing apoptosis induced by a large number of stress factors. However, the molecular mechanisms by which a-crystallins suppress apoptosis remain largely unknown until our recent studies in which we have demonstrated that a-crystallins are capable of abrogating the apoptotic process in several different mechanisms. First, by interacting with procaspase-3 and the partially processed intermediate, a B - crystallin can repress activation of procaspase-3 and thus prevent stress-induced apoptosis. Second, through interactions with Bax and Bcl-Xs, aA- and aB-crystallins can sequester their translocation into mitochondria to block stress-induced apoptosis. Finally, by repressing the RAS/RAF/MEK/ERK signaling pathway, aB-crystallin is able to intervene UVA- and other stress-induced apoptosis. In contrast, aA-crystallin is found capable of promoting activation of the Akt surviving pathway to counteract UVA- and other stress-induced apoptosis. Our observations have been confirmed by recent studies from numerous laboratories. Major findings from these laboratories are 1) alphaBcrystallin interacts with caspase-3 and its precursors in cardiomyocytes and neuroglial cells besides in lens epithelial cells; 2) knockout of both a-crystallins leads to upregulation of caspase-3 and caspase-6 in the fiber cell zone of the ocular lens where secondary lens fiber cell disintegration occurs, causing apoptosis and cataract; 3). The total and phospho-ERKl 12 and p38 are much enhanced in the astrocytes of the aB(-I-) mice than in those from normal mice with the same genetic background; Finally, Member of the heat shock protein family, hsp60, directly interacts with Bax; Based on these results together, we hypothesize that a-crystallins can modulate multiple steps and signaling pathways, which are fundamental to both lens differentiation and lens pathology.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.2174/15665240113139990061
发表时间:
2013-08
期刊:
Current molecular medicine
影响因子:
2.5
作者:
[W-b Liu;X-H Hu;X-W Zhang;M. Deng;L. Nie;S. Hui;W. Duan;M. Tao;C. Zhang;J. Liu;W-F Hu;Z-X Huang;L. Li;M. Yi;T-T Li-T;L. Wang;Y. Liu;S. Liu;D. W. Li]
通讯作者:
W-b Liu;X-H Hu;X-W Zhang;M. Deng;L. Nie;S. Hui;W. Duan;M. Tao;C. Zhang;J. Liu;W-F Hu;Z-X Huang;L. Li;M. Yi;T-T Li-T;L. Wang;Y. Liu;S. Liu;D. W. Li
Towards better understanding on psychiatric disorder, ocular diseases, heart disease and cancer.
更好地了解精神疾病、眼部疾病、心脏病和癌症。
DOI:
10.2174/1566524011313060001
发表时间:
2013
期刊:
Current molecular medicine
影响因子:
2.5
作者:
[Li,DavidWan-Cheng]
通讯作者:
Li,DavidWan-Cheng
DOI:
10.2174/1566524011307010001
发表时间:
2012-12
期刊:
Current Molecular Medicine
影响因子:
2.5
作者:
[David Wan-Cheng]
通讯作者:
David Wan-Cheng
DOI:
10.2174/1566524011313090067
发表时间:
2013-06
期刊:
Current molecular medicine
影响因子:
2.5
作者:
[L. Li;L. Wang;T-T Li-T;X. Li;X.–Q. Huang;X-W Chen;Z. Li;X. Lv;F-Y Liu;Z-W Luo;M. Liu;X-H Hu;W-F Hu;Z-X Huang;M. Yi;S. Liu;Y.-Z. Liu;D. W. Li]
通讯作者:
L. Li;L. Wang;T-T Li-T;X. Li;X.–Q. Huang;X-W Chen;Z. Li;X. Lv;F-Y Liu;Z-W Luo;M. Liu;X-H Hu;W-F Hu;Z-X Huang;M. Yi;S. Liu;Y.-Z. Liu;D. W. Li
Still water runs deep.
静水流深。
DOI:
10.2174/1566524015666150114103825
发表时间:
2015
期刊:
Current molecular medicine
影响因子:
2.5
作者:
[Li,DavidWan-Cheng]
通讯作者:
Li,DavidWan-Cheng
Regulation of Apoptotic Signaling Pathways by Alpha-Crystallins in the Ocular Len
-
批准号:7737614
-
项目类别:
-
资助金额:$51.25万
-
财政年份:2009
-
负责人:David W Li
-
依托单位:
Antiapoptotic Mechanism of Protein Phosphatase-1 in Lens
-
批准号:7257054
-
项目类别:
-
资助金额:$28.55万
-
财政年份:2005
-
负责人:David W Li
-
依托单位:
Antiapoptotic Mechanism of Protein Phosphatase-1 in Lens
-
批准号:6917472
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2005
-
负责人:David W Li
-
依托单位:
Antiapoptotic Mechanism of Protein Phosphatase-1 in Lens
-
批准号:7057223
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2005
-
负责人:David W Li
-
依托单位:
APOPTOSIS--LENS DIFFERENTIATION AND CATARACT DEVELOPMENT
-
批准号:6180043
-
项目类别:
-
资助金额:$12.64万
-
财政年份:1996
-
负责人:David W Li
-
依托单位:
APOPTOSIS--LENS DIFFERENTIATION AND CATARACT DEVELOPMENT
-
批准号:2907082
-
项目类别:
-
资助金额:$4.83万
-
财政年份:1996
-
负责人:David W Li
-
依托单位:
APOPTOSIS--LENS DIFFERENTIATION AND CATARACT DEVELOPMENT
-
批准号:2165697
-
项目类别:
-
资助金额:$11.33万
-
财政年份:1996
-
负责人:David W Li
-
依托单位:
APOPTOSIS--LENS DIFFERENTIATION AND CATARACT DEVELOPMENT
-
批准号:2711170
-
项目类别:
-
资助金额:$7.13万
-
财政年份:1996
-
负责人:David W Li
-
依托单位:
APOPTOSIS--LENS DIFFERENTIATION AND CATARACT DEVELOPMENT
-
批准号:2430396
-
项目类别:
-
资助金额:$11.64万
-
财政年份:1996
-
负责人:David W Li
-
依托单位:
APOPTOSIS--LENS DIFFERENTIATION AND CATARACT DEVELOPMENT
-
批准号:2888501
-
项目类别:
-
资助金额:$12.27万
-
财政年份:1996
-
负责人:David W Li
-
依托单位:
OXIDATIVE STRESS AND GENE EXPRESSION IN LENS SYSTEM
-
批准号:2160442
-
项目类别:
-
资助金额:$2.27万
-
财政年份:1994
-
负责人:David W Li
-
依托单位:
OXIDATIVE STRESS AND GENE EXPRESSION IN LENS SYSTEM
-
批准号:2160443
-
项目类别:
-
资助金额:$2.86万
-
财政年份:1994
-
负责人:David W Li
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: